Christopher McFadden

Christopher D. McFadden (San Francisco) joined KKR in 2018 and is a Managing Director focused on cross-asset class U.S. healthcare investing. Prior to joining the Firm, Mr. McFadden was a senior advisor for Athyrium Capital Management and a managing partner of Canyon Healthcare Partners. Previously, he was a partner at Health Evolution Partners and a managing director at Goldman Sachs, including serving in leadership roles in global investment research (GIR) and Americas special situations group (AmSSG). Mr. McFadden is a Chartered Financial Analyst (CFA).